2016 | Novel oral transforming growth factor- signaling inhibitor EW-7197 eradicates CML-initiating cells | 신윤용; 김대기 | Article |
2010 | Novel ALK5 Inhibitor Inhibits Breast Tumor Metastasis and Increases the Interactions of SnoN and Ski to the Promoters of TGF beta Target Genes. | 신윤용; 김대기 | Meeting Abstract |
2015 | Antitubercular activities of the novel synthesized 1,2,4-triazole derivatives | 신윤용; 박혜영; 김대기 | Article |
2011 | EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung | 신윤용; 김대기 | Article |
2010 | Synthesis and biological evaluation of 4(5)-(6-methylpyridin-2-yl)imidazoles and -pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors | 신윤용; 김대기 | Article |
2014 | EW-7197, a novel ALK-5 kinase inhibitor, potently inhibits breast to lung metastasis | 신윤용; 김대기 | Article |
2011 | Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin- 2-yl)-4-(quinoxalin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors | 신윤용; 김대기 | Article |
2011 | Synthesis and biological evaluation of 1-substituted-3-(6-methylpyridin-2- yl)-4-([1,2,4triazolo[1,5-apyridin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors | 신윤용; 김대기 | Article |
2011 | Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin- 2-yl)-4-(quinolin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors | 신윤용; 김대기 | Article |
2015 | Synthesis and biological evaluation of 5-(fluoro-substituted-6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-alpha]pyridin-6-yl)imidazoles as inhibitors of transforming growth factor-beta type I receptor kinase | 신윤용; 김대기 | Article |